Neurocrine Biosciences (NBIX) EBT (2010 - 2026)
Neurocrine Biosciences' EBT was $162.2 million in Q2 2026, up 1.7% from $159.5 million a year earlier but down 34.3% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EBT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurocrine Biosciences' EBT was $940.2 million through Jun 30, 2026, up 78.4% year-over-year; for FY2025, it came in at $705.4 million, up 45.1% from FY2024.
- EBT has now increased for four consecutive years, with a five-year compound annual growth rate of 45.9% (FY2020 to FY2025).
- In earlier years, EBT was $486 million in FY2024 (+46.3%), $332.1 million in FY2023 (+55.3%), $213.9 million in FY2022 (+110.9%) and $101.4 million in FY2021 (-5.0%).
- Quarterly EBT has moved between -$103.3 million (Q1 2023) and $291.8 million (Q3 2025) over five years.
- Compared with a year earlier, EBT was higher in five of the last seven quarters, with growth averaging 21.9%.
- The best year-over-year quarter for EBT over five years was Q3 2022 (growth of 221.0%); the worst was Q1 2025 (a decline of 57.4%).
- Per Business Quant data, NBIX's EBT in the three quarters before Q2 2026 was $246.8 million (Q1 2026), $239.4 million (Q4 2025) and $291.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 162.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 162.20 Mn |
| Mar 31, 2026 | 246.80 Mn |
| Dec 31, 2025 | 239.40 Mn |
| Sep 30, 2025 | 291.80 Mn |
| Jun 30, 2025 | 159.50 Mn |
| Mar 31, 2025 | 14.70 Mn |
| Dec 31, 2024 | 162.60 Mn |
| Sep 30, 2024 | 190.30 Mn |
| Jun 30, 2024 | 98.60 Mn |
| Mar 31, 2024 | 34.50 Mn |
| Dec 31, 2023 | 198.20 Mn |
| Sep 30, 2023 | 115.60 Mn |
| Jun 30, 2023 | 121.60 Mn |
| Mar 31, 2023 | -103.30 Mn |
| Dec 31, 2022 | 117.90 Mn |
| Sep 30, 2022 | 97.90 Mn |
| Jun 30, 2022 | -23.30 Mn |
| Mar 31, 2022 | 21.40 Mn |
| Dec 31, 2021 | -13.80 Mn |
| Sep 30, 2021 | 30.50 Mn |
API Access
Neurocrine Biosciences EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();